Gynecological Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Gynecological Devices Market is segmented By Product (Surgical devices (Gynecological Endoscopy Devices (Hysteroscope, Colposcope, Resectoscope, Laparoscope, Endoscopic imaging systems, Fluid Management Systems), Endometrial Ablation Devices (Hydrothermal ablation devices, Radiofrequency ablation devices, Balloon ablation devices, Others (microwave, laser), Female Sterilization/Contraceptive Devices (Permanent Birth Control, Intra-Uterine Devices (IUD), Intravaginal rings, Subdermal Contraceptive Implants)), Hand Instruments (Vaginal Speculum, Tenaculum, Curettes, Trocars, Biopsy Forceps, Dilators, Scissors, Others), Diagnostic Imaging Systems (MRI, Ultrasound, CT, Radiology, Others), Software), By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

The global gynecological Market reached US$ 15.4 billion in 2023 and is expected to reach US$ 26.9 billion by 2031, growing at a CAGR of 6.8% during the forecast period 2024-2031

Gynecological devices are medical tools and equipment used to diagnose, treat, and manage conditions related to the female reproductive system. They support both preventive and therapeutic approaches, and are used in various applications such as prenatal care, cancer screening, and infertility treatments. From basic tools like speculums and colposcopes to advanced technologies like robotic surgical systems and ultrasound machines, they enhance women's health outcomes and quality of life.

Report Scope

Market Dynamics: Drivers & Restraints

Advancements in the gynecological devices

Advanced laparoscopic robotic surgery is used in gynaecology for procedures like hysterectomies, myomectomies, endometriosis resection, and pelvic organ prolapse repairs. Its precision reduces the risk of damage to surrounding tissues and organs, resulting in fewer complications. Smaller incisions reduce postoperative pain, hospital stays, and recovery times. The enhanced visualisation and maneuverability improve the surgeon's ability to remove endometrial implants and fibroids, increasing procedure success rates.

For instance, in April 2024, the Franche-Comte Polyclinic, part of ELSAN, the leading private hospital group in France, and Moon Surgical, a French-American pioneer in collaborative robotics, announced that the Maestro System is now being used clinically in gynecological laparoscopic procedures.         

Stringent regulatory requirements

The global gynecological devices market faces challenges such as stringent regulatory requirements, high costs, shortage of skilled healthcare professionals, cultural and social stigmas, and complications and risks. These factors can hinder the growth of the market, especially in low-income regions, and limit access to advanced gynecological procedures. Additionally, cultural and social stigmas can create barriers to awareness and usage, and complications and risks may lead to reluctance among patients and healthcare providers.

Segment Analysis

The global gynecological devices market is segmented based on product type, application, end user and region.

The diagnostic devices from the product type segment accounted for approximately 41.3% of the gynecological devices  market share

The diagnostic devices from the product type segment accounted for approximately 41.3%. Diagnostic devices, such as ultrasound systems, colposcopes, hysteroscopes, and mammography machines, are vital in the global gynecological devices market for early detection, diagnosis, and monitoring of various conditions like cervical cancer, ovarian cysts, endometriosis, and other reproductive health disorders. Advancements in imaging technologies have improved the accuracy and efficiency of these diagnostic tools, leading to better patient outcomes and promoting preventive care and treatment planning.

For instance, in September 2024, Samsung Medison, a global medical equipment company, will showcase its HERA Z20 ultrasound system at the 34th annual ISUOG World Congress 2024 in Budapest. The premium ultrasound system, which is considered the most important in the field of OB&GYN ultrasound, features advanced AI diagnostic assistance features to improve women's and fetuses' health. The Live ViewAssist feature provides real-time diagnosis location, reduces measurement time, and increases accuracy by automatically classifying cross sections and providing measurement results for the entire quarter of OB&GYN.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period         

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to novel product launches, FDA approvals, presence of a well-established healthcare infrastructure, rising levels of awareness regarding the availability of diagnostic tests & treatments, and developed reimbursement coverage.

For instance, in September 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the market launch of the Guardenia Contained Extraction System. Guardenia is the latest innovation in their contained tissue extraction product portfolio for gynecological procedures and is manufactured by Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland.

Market Segmentation

By Product Type

• Diagnostic Devices
• Surgical Devices
• Monitoring Devices

By Application

• Obstetrics
• Gynecology
• Fertility
• Others

By End User

• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include B. Braun Melsungen AG, Medtronic Plc, Cooper Surgical, Inc, Richard Wolf GmbH, Hologic, Inc, Boston Scientific Corporation, Stryker Corporation, Karl Storz GmbH & Co. KG, Ethicon, Inc, MedGyn Products among others.

Key Developments

• In April 2024, GE HealthCare announced that it launched the Voluson Signature 20 and 18 ultrasound systems for women’s health imaging applications. Chicago-based GE HealthCare designed the systems to integrate AI, advanced tools and an ergonomic design. They speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health. The latest systems combine high-performance hardware with flexible, scalable software to help increase confidence in diagnostic and treatment decisions.

Why Purchase the Report?

• To visualize the global gynecological devices market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the gynecological devices market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global gynecological devices market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

For more medical devices-related reports, please click here